Stay updated on Azacitidine and Pembrolizumab in MDS Clinical Trial

Sign up to get notified when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine and Pembrolizumab in MDS Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:45:27.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-18T15:48:09.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T15:48:11.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden message with minimal navigation, replacing the previously expected study-record content.
    Difference
    19%
    Check dated 2026-09-20T20:04:10.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.5 to v3.6.6, indicating a small maintenance release. This signals a new version of the page without altering substantive content.
    Difference
    0.1%
    Check dated 2026-08-30T08:12:35.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    The page's revision label has advanced from v3.6.4 to v3.6.5, signaling an update to the site's revision version. This appears to be a metadata/version bump and does not modify the study content or user-facing features.
    Difference
    0.1%
    Check dated 2026-08-08T23:39:08.000Z thumbnail image

Stay in the know with updates to Azacitidine and Pembrolizumab in MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.